Recent grants
Research projects
Katherine Stevens has been awarded an ESRC/MRC/NIHR Early Career Post Doctoral fellowship in Economics of Health to study the application of a new paediatric preference based health related quality of life measure: the Child Health Utility 9D (£176,640, 4 years part-time).
John Brazier has been awarded an NIHR Senior Investigator Award.
John Brazier won a grant from the Medical Research Council: "Validating generic preference-based measures of health in mental health populations and estimating mapping functions for widely used specific measures" (£222,313).
John Brazier won a grant from Epilepsy Research UK: "Health economic evaluations in epilepsy: developing a preference-based outcome measure" (£67,305).
Jim Chilcott, Paul Tappenden and Sophie Whyte have been awarded a grant from the NHS Cancer Screening Programme to assess the capacity implication of expanding the bowel cancer screening up to age 74 (£101,199).
Roberta Ara won a grant of £62K from the Department of Health for the Anti-Obesity Drugs in Primary Care project.
Steve Goodacre, Matt Stevenson and Simon Dixon won a grant of £184K to investigate the cost-effectiveness of diagnostic strategies for minor head injuries.
John Brazier is a member of a team led by Liddy Goyder that recently won a £1.2 million grant (2009-12) from the NIHR HTA to work on RCT and CE evaluation of a "Booster" intervention to sustain increases in physical activities in middle-aged adults in deprived neighbourhoods.
John Brazier has won a grant of £151,000 (2008-10) subject to contract from the NIHR HTA Methods Programme to work on the development and testing of methods for deriving preference-based measures from condition-specific measures.
John Brazier and Sube Banerjee have won a grant of £550,000 (2008-10) subject to contract from the NIHR HTA Methods Programme to work on generation of preference-based measures from the DEMQoL and DEMQoL proxy for use in economic evaluation.
John Brazier has won a £220,000 grant from Merck (2008-10) to work on a review and empirical study of health related quality of life instruments for measuring the impact of oral medication versus insulin injection.
Consultancy projects
Ron Akehurst, Edith Poku and Katy Cooper: Use of amphetamines including Vyvanse for treatment-resistant unipolar depression: evidence synthesis (Shire).
Roberta Ara, Ron Akehurst and Allan Wailoo: Scientific Advice Programme (NICE). 18 month contract for a minimum of 10 projects per year.
Alan Brennan and Rachid Rafia: Estimating alcohol related injuries and deaths for England and Wales (NICE).
Chris Carroll (collaboration with Institute of Work Psychology, Sheffield University): National Policing Improvement Agency (NPIA).
Mike Gillett, Katy Cooper, Alan Brennan: Analysis of the economic impact of hypoglycaemic events – comparison of vildagliptin versus sulfonylurea (Novartis).
Mike Gillett, John Stevens, Katy Cooper, Alan Brennan: Bayesian mixed treatment comparisons of vildagliptin versus sitagliptin (Januvia) in type II diabetes (Novartis).
Allan Wailoo (Decision Support Unit): Sourcing expertise to support Scientific Advice Programme (NICE).
John Brazier has won a grant from Janssen-Cilag (2008-9) to work on estimation of a preference-based single index measure of health from the EORTC QLQ-C30 for use in multiple myeloma patients.
Ron Akehurst and Sue Ward are working on a proposal for the preparation of the NICE submission of imatinib for the treatment of GIST. This is for Novartis.
Jim Chilcott, Sophie Whyte and Paul Tappenden are working on analytical support to the bowel cancer screening programme in England for NHS Cancer Screening.
Sue Ward is working for PAI (GSK) on a proposal to develop UK versions of Excel-based cost-effectiveness and budgetary-impact models for ofatumumab in relapsed/refractory chronic lymphocytic leukaemia (CLL).